{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:53:34Z","timestamp":1793159614328,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,3,7]],"date-time":"2006-03-07T00:00:00Z","timestamp":1141689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s00213-006-0343-1","type":"journal-article","created":{"date-parts":[[2006,3,6]],"date-time":"2006-03-06T17:50:34Z","timestamp":1141667434000},"page":"524-528","source":"Crossref","is-referenced-by-count":160,"title":["Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia"],"prefix":"10.1007","volume":"185","author":[{"given":"Sebastian","family":"Walther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Mahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Eichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,7]]},"reference":[{"key":"343_CR1","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington, DC","edition":"4"},{"key":"343_CR2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/sleep\/20.1.24","volume":"20","author":"S Ancoli-Israel","year":"1997","unstructured":"Ancoli-Israel S, Clopton P, Klauber MR, Fell R, Mason W (1997) Use of wrist activity for monitoring sleep\/wake in demented nursing-home patients. Sleep 20:24\u201327","journal-title":"Sleep"},{"key":"343_CR3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4088\/JCP.v65n0120","volume":"65","author":"CG Ballard","year":"2004","unstructured":"Ballard CG, Thomas A, Fossey J, Lee L, Jacoby R, Lana MM, Bannister C, McShane R, Swann A, Juszczak E, O\u2019Brien JT (2004) A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. J Clin Psychiatry 65:114\u2013119","journal-title":"J Clin Psychiatry"},{"key":"343_CR4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/nbdi.1998.0229","volume":"5","author":"CS Breivogel","year":"1998","unstructured":"Breivogel CS, Childers SR (1998) The functional neuroanatomy of brain cannabinoid receptors. Neurobiol Dis 5:417\u2013431","journal-title":"Neurobiol Dis"},{"key":"343_CR5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.323.7303.13","volume":"323","author":"FA Campbell","year":"2001","unstructured":"Campbell FA, Tramer MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ (2001) Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 323:13\u201316","journal-title":"BMJ"},{"key":"343_CR6","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308\u20132314","journal-title":"Neurology"},{"key":"343_CR7","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1212\/WNL.56.9.1154","volume":"56","author":"R Doody","year":"2001","unstructured":"Doody R, Stevens J, Beck C, Dubinsky R, Kaye J, Gwyther L, Mohs R, Thal LJ, Whitehouse P, DeKosky ST, Cummings JL (2001) Practice parameter: management of dementia (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 56:1154\u20131166","journal-title":"Neurology"},{"key":"343_CR8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"343_CR9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","volume":"42","author":"F Grotenhermen","year":"2003","unstructured":"Grotenhermen F (2003) Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 42:327\u2013360","journal-title":"Clin Pharmacokinet"},{"key":"343_CR10","doi-asserted-by":"crossref","first-page":"M693","DOI":"10.1093\/gerona\/56.11.M693","volume":"56","author":"R Hebert","year":"2001","unstructured":"Hebert R, Dubois MF, Wolfson C, Chambers L, Cohen C (2001) Factors associated with long-term institutionalization of older people with dementia: data from the Canadian Study of Health and Aging. J Gerontol A Biol Sci Med Sci 56:M693\u2013M699","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"343_CR11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1192\/bjp.174.1.39","volume":"174","author":"T Hope","year":"1999","unstructured":"Hope T, Keene J, Fairburn CG, Jacoby R, McShane R (1999) Natural history of behavioural changes and psychiatric symptoms in Alzheimer\u2019s disease. A longitudinal study. Br J Psychiatry 174:39\u201344","journal-title":"Br J Psychiatry"},{"key":"343_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161\u2013202","journal-title":"Pharmacol Rev"},{"key":"343_CR13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.38125.465579.55","volume":"329","author":"PE Lee","year":"2004","unstructured":"Lee PE, Gill SS, Freedman M, Bronskill SE, Hillmer MP, Rochon PA (2004) Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ 329:75\u201379","journal-title":"BMJ"},{"key":"343_CR14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/01.jcp.0000132443.12607.fd","volume":"24","author":"R Mahlberg","year":"2004","unstructured":"Mahlberg R, Kunz D, Sutej I, Kuhl KP, Hellweg R (2004) Melatonin treatment of day\u2013night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy. J Clin Psychopharmacol 24:456\u2013459","journal-title":"J Clin Psychopharmacol"},{"key":"343_CR15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34:939\u2013944","journal-title":"Neurology"},{"key":"343_CR16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.npp.1300047","volume":"28","author":"KR Muller-Vahl","year":"2003","unstructured":"Muller-Vahl KR, Prevedel H, Theloe K, Kolbe H, Emrich HM, Schneider U (2003a) Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance. Neuropsychopharmacology 28:384\u2013388","journal-title":"Neuropsychopharmacology"},{"key":"343_CR17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4088\/JCP.v64n0417","volume":"64","author":"KR Muller-Vahl","year":"2003","unstructured":"Muller-Vahl KR, Schneider U, Prevedel H, Theloe K, Kolbe H, Daldrup T, Emrich HM (2003b) Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. J Clin Psychiatry 64:459\u2013465","journal-title":"J Clin Psychiatry"},{"key":"343_CR18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/sleep\/26.8.943","volume":"26","author":"E Murillo-Rodriguez","year":"2003","unstructured":"Murillo-Rodriguez E, Blanco-Centurion C, Sanchez C, Piomelli D, Shiromani PJ (2003) Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. Sleep 26:943\u2013947","journal-title":"Sleep"},{"key":"343_CR19","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","volume":"23","author":"BG Ramirez","year":"2005","unstructured":"Ramirez BG, Blazquez C, Gomez dP, Guzman M, de Ceballos ML (2005) Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 23:1904\u20131913","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"343_CR20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S1041610292001157","volume":"4","author":"SG Sclan","year":"1992","unstructured":"Sclan SG, Reisberg B (1992) Functional assessment staging (FAST) in Alzheimer\u2019s disease: reliability, validity, and ordinality. Int Psychogeriatr 4(Suppl 1):55\u201369","journal-title":"Int Psychogeriatr"},{"key":"343_CR21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.38149.566979.AE","volume":"329","author":"KB Svendsen","year":"2004","unstructured":"Svendsen KB, Jensen TS, Bach FW (2004) Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 329:253","journal-title":"BMJ"},{"issue":"Suppl 8","key":"343_CR22","first-page":"11","volume":"60","author":"PN Tariot","year":"1999","unstructured":"Tariot PN (1999) Treatment of agitation in dementia. J Clin Psychiatry 60(Suppl 8):11\u201320","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 11","key":"343_CR23","first-page":"11","volume":"65","author":"PN Tariot","year":"2004","unstructured":"Tariot PN, Profenno LA, Ismail MS (2004) Efficacy of atypical antipsychotics in elderly patients with dementia. J Clin Psychiatry 65(Suppl 11):11\u201315","journal-title":"J Clin Psychiatry"},{"key":"343_CR24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/bmj.323.7303.16","volume":"323","author":"MR Tramer","year":"2001","unstructured":"Tramer MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ (2001) Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 323:16\u201321","journal-title":"BMJ"},{"key":"343_CR25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D","volume":"12","author":"L Volicer","year":"1997","unstructured":"Volicer L, Stelly M, Morris J, McLaughlin J, Volicer BJ (1997) Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer\u2019s disease. Int J Geriatr Psychiatry 12:913\u2013919","journal-title":"Int J Geriatr Psychiatry"},{"key":"343_CR26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1176\/appi.ajp.158.5.704","volume":"158","author":"L Volicer","year":"2001","unstructured":"Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A (2001) Sundowning and circadian rhythms in Alzheimer\u2019s disease. Am J Psychiatry 158:704\u2013711","journal-title":"Am J Psychiatry"},{"key":"343_CR27","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","volume":"296","author":"RI Wilson","year":"2002","unstructured":"Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296:678\u2013682","journal-title":"Science"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0343-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-006-0343-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0343-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:31:18Z","timestamp":1558629078000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-006-0343-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["343"],"URL":"https:\/\/doi.org\/10.1007\/s00213-006-0343-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,7]]}}}